Department of Research Infrastructure Division of Biobank
List of our Programs
- Program for Promoting Platform of Genomics based Drug Discovery
- Program for an Integrated Database of Clinical and Genomic Information
- Platform Program for Promotion of Genome Medicine
- National BioResource Project (NBRP)
- Tohoku Medical Megabank Project
- Public Understanding and Information Sharing on Research Ethics (Ethical, legal and social issues on the practical application of genome medicine)
- Tailor-Made Medical Treatment with the BioBank Japan Project (BBJ)
List of our News
2018.12.26International survey on medical R&D strategy planning method based on public health information
2016.9.7Genetic Diversity of Enzymes Alters Metabolic Individuality
Profile of the Division of Biobank
In light of the rapid progress in analysis technology at the genomic level, the Division of Biobank strives to strengthen the foundation of genome analysis while encouraging R&D to clarify how genetic and environmental factors relate to specific diseases and promote clinical applications of the findings with the aim of swiftly returning to the public the benefits of the clarification.
Specifically, while working to establish a biobank for specimens of diseases and healthy donors, the department analyzes such data as genome analysis information and clinical information to identify and verify the genes related to the onset of diseases and drug responsiveness and to identify the standard genome sequence of Japanese people. In addition, through collaborative and ancillary genome research, the department not only aims to track down the causal genes of rare/intractable diseases, but also to contribute to the formulation of innovative diagnostic/treatment guidelines based on genome information. Furthermore, the department is pushing forward experimental/empirical clinical research to strengthen the research foundation and establish a system for offering genomic medical care toward the goal of turning genomic medicine into reality.
Through these initiatives, the department aims to achieve the following by 2020.
- To find evidence associated with risk prediction/prevention, diagnosis (stratification), treatment, and drug selection/optimization for diabetes and other diseases
- To commence clinical research associated with predictive cancer diagnostics and treatment responses to anticancer and other drugs, and prediction of their side effects
- To commence clinical research associated with genomic medicine in the fields of dementia and sensory systems
- To commence clinical research associated with innovative methods of diagnosis and treatment for intractable neuromuscular diseases
Under AMED's Japan Genomic Medicine Project, the Data-sharing Policy for the Realization of Genomic Medicine was formulated to clarify the policy to be followed with respect to the sharing of genome information with the aim of promoting data sharing in related fields.
Furthermore, under the National BioResource Project, bioresources such as experimental animals, plants and micro-organisms that are of fundamental importance in life science research and critical for the nation to strategically organize are systematically collected, preserved and provided. In addition, with the aim of enhancing the quality of bioresources, efforts are made to secure bioresources that meet the needs of the time by developing preservation technologies and adding more value to them by way of genome analysis.